Here's the live share price of Goldline Pharmaceutical along with daily highs, lows, percentage changes and volume trends, and, all financial information.
Source: Dion Global
Source: Dion Global
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Goldline Pharmaceutical | 10.06 | -16.72 | -16.72 | -16.72 | -16.72 | -5.92 | -3.59 |
| Sun Pharmaceutical Industries | 1.09 | -3.93 | -1.43 | -0.45 | 6.35 | 22.22 | 21.43 |
| Divi's Laboratories | 1.18 | -0.63 | 5.08 | 3.73 | -0.69 | 24.74 | 9.01 |
| Torrent Pharmaceuticals | 5.81 | 1.56 | 3.62 | 20.75 | 43.17 | 36.38 | 26.09 |
| Cipla | -1.06 | 6.00 | 3.99 | -8.54 | -9.13 | 12.95 | 7.40 |
| Zydus Lifesciences | 1.86 | 15.58 | 19.92 | 19.86 | 12.97 | 29.43 | 10.70 |
| Dr. Reddy's Laboratories | 0.63 | -0.36 | -3.81 | 0.16 | -5.59 | 10.90 | 3.18 |
| Lupin | 1.17 | 1.31 | -3.01 | 9.36 | 12.20 | 40.57 | 13.08 |
| Mankind Pharma | 1.17 | -3.53 | 6.18 | 9.94 | 0.16 | 17.33 | 10.84 |
| Aurobindo Pharma | -0.06 | -1.56 | 12.11 | 24.75 | 26.07 | 30.15 | 7.68 |
| Laurus Labs | -2.40 | 9.98 | 33.92 | 36.82 | 105.84 | 59.45 | 17.90 |
| Biocon | 0.17 | 6.63 | 5.32 | 9.13 | 17.53 | 20.30 | 0.07 |
| Alkem Laboratories | 0.47 | -5.31 | -4.22 | -5.76 | 8.48 | 16.56 | 10.65 |
| Glenmark Pharmaceuticals | -1.57 | -8.63 | -5.51 | 9.76 | 31.25 | 49.82 | 26.90 |
| Abbott India | 0.76 | -6.29 | -4.34 | -7.79 | -17.69 | 5.84 | 9.78 |
| Anthem Biosciences | 4.62 | -0.51 | 20.29 | 13.86 | 6.80 | 2.22 | 1.32 |
| Ipca Laboratories | 0.10 | 5.76 | 5.83 | 10.30 | 16.72 | 30.43 | 9.65 |
| Ajanta Pharma | 6.62 | 2.54 | 3.20 | 18.57 | 18.71 | 29.84 | 19.16 |
| Gland Pharma | 3.81 | 20.07 | 38.42 | 36.19 | 37.11 | 34.09 | -6.05 |
| J B Chemicals & Pharmaceuticals | 6.44 | 2.77 | 6.80 | 25.09 | 32.14 | 28.50 | 24.12 |
Source: Dion Global
Over the last one year, Goldline Pharmaceutical has declined 16.72% compared to peers like Sun Pharmaceutical Industries (6.35%), Divi's Laboratories (-0.69%), Torrent Pharmaceuticals (43.17%). From a 5 year perspective, Goldline Pharmaceutical has underperformed peers relative to Sun Pharmaceutical Industries (21.43%) and Divi's Laboratories (9.01%).
Source: Dion Global
| Day | SMA | EMA |
|---|---|---|
| 5 | 43.7 | 44.08 |
| 10 | 44.7 | 45.51 |
| 20 | 35.2 | 0 |
| 50 | 14.08 | 0 |
| 100 | 7.04 | 0 |
| 200 | 3.52 | 0 |
Source: Dion Global
Date Time | Announcement |
|---|---|
| Jun 10, 2026, 12:37 AM IST IST | Goldline Pharma. - Announcement under Regulation 30 (LODR)-Change in Management |
| Jun 10, 2026, 12:30 AM IST IST | Goldline Pharma. - Board Meeting Outcome for Outcome Of Board Meeting Held Today, I.E., 09Th June, 2026 |
| Jun 10, 2026, 12:25 AM IST IST | Goldline Pharma. - Outcome Of Board Meeting Held Today, I.E., 09Th June, 2026 |
| Jun 02, 2026, 09:31 PM IST IST | Goldline Pharma. - Board Meeting Intimation for Intimation Of Board Meeting Under Regulation 29 Of The SEBI (Listing Obligati |
| May 19, 2026, 01:35 PM IST IST | Goldline Pharma. - Listing of Equity Shares of Goldline Pharmaceutical Ltd |
Source: Dion Global
Goldline Pharmaceutical Ltd. is a Public Limited Listed company incorporated on 02/08/2004 and has its registered office in the State of Maharashtra, India. Company's Corporate Identification Number(CIN) is U51397MH2004PLC147806 and registration number is 147806. Currently company belongs to the Industry of Pharmaceuticals. Company's Total Operating Revenue is Rs. 28.06 Cr. and Equity Capital is Rs. 6.90 Cr. for the Year ended 31/03/2025.
Source: Dion Global
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Goldline Pharmaceutical is ₹47.28 as on Jun 11, 2026.
The Goldline Pharmaceutical is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.
The market cap of Goldline Pharmaceutical is ₹45.39 Cr as on Jun 11, 2026.
Today’s highest and lowest price of Goldline Pharmaceutical are ₹49.93 and ₹45.00.
The 52-week high/low is the highest and lowest price at which Goldline Pharmaceutical stock has traded in the past 52-week or nearly a year. The 52-week high of Goldline Pharmaceutical is ₹60.00 and 52-week low of Goldline Pharmaceutical is ₹41.76 as on Jun 11, 2026.
The Goldline Pharmaceutical has shown returns of -3.41% over the past day, -16.72% for the past month, -16.72% over 3 months, -16.72% over 1 year, -5.92% across 3 years, and -3.59% over 5 years.
P/E ratio of and PB ratio of Goldline Pharmaceutical are 11.03 and 3.43 on Jun 11, 2026. While the company gives a dividend yield of 0.00 per annum.
Source: Dion Global